Improved non-invasive blood glucose monitoring device
Award last edited on: 7/17/03

Sponsored Program
Awarding Agency
Total Award Amount
Award Phase
Solicitation Topic Code

Principal Investigator
Abdel-Halim Ghanem

Company Information

Aciont Inc

615 Arapeen Drive Suite #302B
Salt Lake City, UT 84108
   (801) 895-4089
Location: Single
Congr. District: 02
County: Salt Lake

Phase I

Contract Number: 1R43DK059690-01A1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
Phase I Amount
The accurate measurement of blood glucose concentration is important in the management of diabetes. Current methods of glucose monitoring involve piercing the skin and collecting blood samples for analysis up to four times daily or more. Even the non-invasive Glucowatch tm glucose monitoring system requires twice daily blood collection for calibration. This original, innovative invention will decrease and maintain the electrical resistance of the skin at a constant level. This allows for a controlled, increased passive or electroosmoticatly driven migration of glucose outwardly through the skin into a biosensor for analysis. By creating a constant permeability and avoiding a capacitance effect, we will be able to reproducibly extract and analyze glucose through the skin, minimizing the need for frequent calibration. Our long-term goal is to commercialize an iontophoretic device that will allow for the accurate and reproducible extraction of glucose from the skin or underlying subcutaneous space. Phase I research will study the linearity between glucose extraction and donor solution concentration in vitro and in vivo and demonstrate the advantage of our approach over the Glucowatch tm We will study glucose flux through human epidermis using a variety of protocols to optimize stratum corneum permeation enhancement and minimize intra- and inter-subject variability.

Thesaurus Terms:
biomedical equipment development, blood glucose, diabetes mellitus, diagnosis design /evaluation, iontophoresis, monitoring device, noninvasive diagnosis biosensor, blood osmolarity, electrical conductance, skin clinical research, human subject

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
Phase II Amount